Does RAGE protect smokers from COPD?

Young R.P., Hay B.A., Hopkins R.J.

Source: Eur Respir J 2011; 38: 743-744
Journal Issue: September
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Young R.P., Hay B.A., Hopkins R.J.. Does RAGE protect smokers from COPD?. Eur Respir J 2011; 38: 743-744

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Do current smoking COPD patients exacerbate more often?
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Does knowledge of smokers about chronic obstructive pulmonary disease (COPD) differ than nonsmokers?
Source: Eur Respir J 2004; 24: Suppl. 48, 372s
Year: 2004

Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers
Source: Eur Respir J 2003; 22: Suppl. 45, 392s
Year: 2003

Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Do COPD smokers differ from healthy smokers in their readiness to stop smoking?
Source: Eur Respir J 2004; 24: Suppl. 48, 249s
Year: 2004

Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD
Source: Eur Respir J 2007; 29: 51-55
Year: 2007



Evidence for harm reduction in diseased smokers
Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited
Year: 2007


COPD patients continue to smoke after being diagnosed for COPD
Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence
Year: 2020


Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Oxidative stress and airway inflammation in healthy smokers and COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002

Decreased pulmonary mature dendritic cells in healthy smokers and smoking COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 212s
Year: 2007

Overexpression of RAGE in lungs of patients with COPD: A contributor to oxidative stress in COPD
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011


Cigarette smoke extract induces ER stress in human lung fibroblasts from COPD patients and healthy subjects
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019

8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006


Identifying the at risk smokers: who goes on to get COPD?
Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019
Year: 2019



Sputum biomarkers of inflammation in smokers and subjects with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Does knowledge of public smokers about lung cancer differ than non-smokers?
Source: Eur Respir J 2005; 26: Suppl. 49, 158s
Year: 2005

Differences in COPD: Smokers versus non smokers
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015